Why parents are reliving their baby-loss nightmares
An inquiry is under way to ensure the deaths of three babies are not brushed off as isolated tragedies.
An inquiry is under way to ensure the deaths of three babies are not brushed off as isolated tragedies.
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Hormones control just about everything in our bodies—from our mood and energy levels to our metabolism and sleep cycles. When they’re in balance, we feel energized, focused, and emotionally stable. But when they’re off? Fatigue, weight gain, acne, anxiety, insomnia, and even digestive issues can follow. The good news? You don’t always need prescriptions to…
In the age of digital connectivity and home-centric lifestyles, establishing a home workout routine has become more than a convenience—it’s a cornerstone of maintaining physical and mental health for many. Whether you’re avoiding the commute to the gym, saving on membership fees, or simply prefer the privacy of your own space, a home workout routine…
Medical personnel use a mammogram to examine a woman’s breast for breast cancer. Hannibal Hanschke | dpa | Picture Alliance | Getty Images SAN FRANCISCO — An established but promising group of cancer drugs was a red-hot market in 2023, and more companies could look to the treatments to fuel growth in the year ahead….
She said many Whorlton Hall patients were “wholly dependent on professional support”, and added: “For each of those sentenced today, it was clear from the evidence in this case that there were occasions where the care they provided was not only devoid of the appropriate respect and kindness required, but also crossed the line into…
Many biotech stocks struggled in 2023 despite a robust year for U.S. drug approvals. As these new therapies begin treating patients, some investors see better times ahead next year. “We’ve seen a lot of innovation,” Dan Lyons, portfolio manager on the health-care team at Janus Henderson, said, explaining that he is bullish on 2024 because…